Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Icecure Medical Ltd ICCM

Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.


NDAQ:ICCM - Post by User

Comment by Iseneschalon Dec 22, 2022 8:48am
109 Views
Post# 35186621

RE:RE:ICCM ..... This whole exercise was all about raising $'s

RE:RE:ICCM ..... This whole exercise was all about raising $'sHi NastyCat....Thx for your reply and I honestly want you to get what you want out of ICCM...GL

I would like to comment on your statement re: financing closes...... All I can say is..... That financing is a done deal.
Notice how the volume started on the 19th....NR after the market closed....then sh price vaulted to over $10 during AH trading.
The volume increased substantially the next day (20th) as the share price opened stronger (albeit lower than AH trading) and ramped up to over $4.50 and closing at $2.60 on a volume of 131 million shares..... Then came the P.O NR right after the close and the share price tanked.
What I'm trying to tell you is ..... the whole financing has been one big Short exercise.....all the volume was laying out John Q Public with high priced paper.
The Shorts will be covered with the P.O....what a game !



<< Previous
Bullboard Posts
Next >>